JRSH NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Jerash Holdings US Inc · Consumer Cyclical · Apparel Manufacturing

Open interactive chart View report data Download investor PDF
Latest close 4.63 USD
2.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 35.3% above the Trend Line and sits at 68.7% of its 52-week range. The latest completed week returned 2.7%, after a 1.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 62/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 59 out of 100
Latest Close 4.63 USD 24 Jul 2026
1W Return 2.7% latest completed week
4W Return 1.5% short-term follow-through
12W Return 33.1% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • The trend backdrop is active with a 13-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.7% Latest completed week; four-week move 1.5%. Indicator stack 69/79 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 62/100 40 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 35.3% above the Trend Line and sits at 68.7% of its 52-week range. The latest completed week returned 2.7%, after a 1.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8912-week average 0.69

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.89Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.5% over four weeks, 33.1% over 12 weeks, and 42.2% over one year. The current trend has remained active for 13 consecutive weeks.

Performance by holding period

1W2.7%
4W1.5%
12W33.1%
26W54.9%
52W42.2%
Active trend streak13 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.58Latest activity-pressure read.
Pressure change2.7%Four-week change in activity pressure.
Leadership29.46Latest relative-leadership reading.
RS change18.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength89/100Blend of value, momentum, and quality. Underlying universe rank 12; rank 1 is best.
Value92/100Relative valuation strength. Underlying universe rank 9; rank 1 is best.
Quality29/100Profitability and accounting quality. Underlying universe rank 72; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth32/100Revenue and earnings growth. Underlying universe rank 69; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
16.6x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
0.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
16.1%
Gross profit retained from each unit of revenue.
Operating margin
300.3%
Operating profit retained from revenue.
Free-cash-flow margin
4.6%
Free cash flow generated from revenue.
Return on invested capital
609.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
123.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.3%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
4.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment62/100

Weighted news tone is positive across 40 relevant articles.

18 positive · 20 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.4%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 268 weeks finished lower.
Best week+29.2%Week of 19 Jun.
Worst week-5.9%Week of 20 Mar.
Latest week+2.7%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains13
Flat weeks1
Modest losses5
Sharp losses3
Recent vol8.0%13-week weekly-return volatility.
Base vol4.9%52-week weekly-return volatility.
Up/down split29/21Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis74/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 6/12.

Activity pressure 0.89; 3 reversal markers Factors72/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 10; Buyback Yield rank 58; Small Cap Core rank 14 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment62/100

Weighted news tone is positive across 40 relevant articles.

Jerash Holdings (US) Inc (JRSH) Shareholder Structure: Major Shareholders & Institutional Holdings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20264.63 USD2.7%3.42 USD2.98 USD1.5829.46373.9KOn
17 Jul 20264.51 USD-1.1%3.37 USD2.97 USD1.6624.55498.9KOn
10 Jul 20264.56 USD2.5%3.31 USD2.96 USD1.8221.08381.7KOn
3 Jul 20264.45 USD-2.4%3.26 USD2.95 USD1.6920.59432.2KOn
26 Jun 20264.56 USD2.0%3.21 USD2.95 USD1.5424.911.4MOn
19 Jun 20264.47 USD29.2%3.16 USD2.94 USD1.3417.2841.0MOn
12 Jun 20263.46 USD1.2%3.11 USD2.93 USD1.02-6.78171.3KOn
5 Jun 20263.42 USD0.6%3.09 USD2.93 USD1.10-6.07595.8KOn
29 May 20263.40 USD4.3%3.08 USD2.93 USD1.19-11.07656.7KOn
22 May 20263.26 USD-1.8%3.08 USD2.93 USD1.36-12.711.0MOn
15 May 20263.32 USD0.3%3.08 USD2.93 USD1.55-10.471.5MOn
8 May 20263.31 USD-4.8%3.07 USD2.93 USD1.35-11.42814.2KOn
1 May 20263.48 USD3.2%3.06 USD2.94 USD1.00-2.35541.6KOn
24 Apr 20263.37 USD6.2%3.05 USD2.94 USD0.50-4.131.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.